Annual D&A:
$12.63M-$535.00K(-4.07%)Summary
- As of today, XERS annual D&A is $12.63 million, with the most recent change of -$535.00 thousand (-4.07%) on December 31, 2024.
- During the last 3 years, XERS annual D&A has risen by +$10.75 million (+571.90%).
- XERS annual D&A is now -4.07% below its all-time high of $13.16 million, reached on December 31, 2023.
Performance
XERS Depreciation & Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly D&A:
$3.16M+$21.00K(+0.67%)Summary
- As of today, XERS quarterly D&A is $3.16 million, with the most recent change of +$21.00 thousand (+0.67%) on June 30, 2025.
- Over the past year, XERS quarterly D&A has increased by +$10.00 thousand (+0.32%).
- XERS quarterly D&A is now -9.68% below its all-time high of $3.50 million, reached on December 31, 2022.
Performance
XERS Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM D&A:
$12.56M+$10.00K(+0.08%)Summary
- As of today, XERS TTM D&A is $12.56 million, with the most recent change of +$10.00 thousand (+0.08%) on June 30, 2025.
- Over the past year, XERS TTM D&A has dropped by -$420.00 thousand (-3.23%).
- XERS TTM D&A is now -6.27% below its all-time high of $13.40 million, reached on September 30, 2023.
Performance
XERS TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
XERS Depreciation & Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -4.1% | +0.3% | -3.2% |
| 3Y3 Years | +571.9% | +3.3% | +71.7% |
| 5Y5 Years | +1071.2% | +895.0% | +796.8% |
XERS Depreciation & Amortization Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -4.1% | +571.9% | -9.7% | +3.0% | -6.3% | +24.8% |
| 5Y | 5-Year | -4.1% | +1071.2% | -9.7% | +888.8% | -6.3% | +796.8% |
| All-Time | All-Time | -4.1% | >+9999.0% | -9.7% | >+9999.0% | -6.3% | >+9999.0% |
XERS Depreciation & Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $3.16M(+0.7%) | $12.56M(+0.1%) |
| Mar 2025 | - | $3.14M(+0.3%) | $12.55M(-0.6%) |
| Dec 2024 | $12.63M(-4.1%) | $3.13M(+0.3%) | $12.63M(-1.0%) |
| Sep 2024 | - | $3.12M(-1.0%) | $12.75M(-1.8%) |
| Jun 2024 | - | $3.15M(-1.9%) | $12.98M(-1.6%) |
| Mar 2024 | - | $3.21M(-1.4%) | $13.19M(+0.3%) |
| Dec 2023 | $13.16M(+3.9%) | $3.26M(-2.9%) | $13.16M(-1.8%) |
| Sep 2023 | - | $3.36M(-0.2%) | $13.40M(+2.2%) |
| Jun 2023 | - | $3.36M(+5.7%) | $13.12M(+2.3%) |
| Mar 2023 | - | $3.18M(-9.2%) | $12.82M(+1.2%) |
| Dec 2022 | $12.67M(+574.2%) | $3.50M(+14.1%) | $12.67M(+25.9%) |
| Sep 2022 | - | $3.07M(+0.3%) | $10.06M(+37.6%) |
| Jun 2022 | - | $3.06M(+1.0%) | $7.32M(+59.9%) |
| Mar 2022 | - | $3.03M(+237.3%) | $4.57M(+143.4%) |
| Dec 2021 | $1.88M | $899.00K(+178.3%) | $1.88M(+31.8%) |
| Sep 2021 | - | $323.00K(+0.9%) | $1.43M(-4.0%) |
| Jun 2021 | - | $320.00K(-5.0%) | $1.49M(+0.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | $337.00K(-24.4%) | $1.48M(+1.2%) |
| Dec 2020 | $1.47M(+36.1%) | $446.00K(+16.4%) | $1.47M(+4.7%) |
| Sep 2020 | - | $383.00K(+20.4%) | $1.40M(+3.2%) |
| Jun 2020 | - | $318.00K(-0.6%) | $1.36M(+7.4%) |
| Mar 2020 | - | $320.00K(-15.8%) | $1.26M(+17.3%) |
| Dec 2019 | $1.08M(+236.9%) | $380.00K(+12.1%) | $1.08M(+23.6%) |
| Sep 2019 | - | $339.00K(+50.7%) | $872.00K(+62.1%) |
| Jun 2019 | - | $225.00K(+67.9%) | $538.00K(+37.6%) |
| Mar 2019 | - | $134.00K(-23.0%) | $391.00K(+22.2%) |
| Dec 2018 | $320.00K(+42.2%) | $174.00K(+3380.0%) | $320.00K(+29.0%) |
| Sep 2018 | - | $5000.00(-93.6%) | $248.00K(-15.9%) |
| Jun 2018 | - | $78.00K(+23.8%) | $295.00K(+35.9%) |
| Mar 2018 | - | $63.00K(-38.2%) | $217.00K(+13.0%) |
| Dec 2017 | $225.00K(+94.0%) | $102.00K(+96.2%) | $192.00K(+113.3%) |
| Sep 2017 | - | $52.00K(+36.8%) | $90.00K(+136.8%) |
| Mar 2017 | - | $38.00K | $38.00K |
| Dec 2016 | $116.00K | - | - |
FAQ
- What is Xeris Biopharma Holdings, Inc. annual D&A?
- What is the all-time high annual D&A for Xeris Biopharma Holdings, Inc.?
- What is Xeris Biopharma Holdings, Inc. annual D&A year-on-year change?
- What is Xeris Biopharma Holdings, Inc. quarterly D&A?
- What is the all-time high quarterly D&A for Xeris Biopharma Holdings, Inc.?
- What is Xeris Biopharma Holdings, Inc. quarterly D&A year-on-year change?
- What is Xeris Biopharma Holdings, Inc. TTM D&A?
- What is the all-time high TTM D&A for Xeris Biopharma Holdings, Inc.?
- What is Xeris Biopharma Holdings, Inc. TTM D&A year-on-year change?
What is Xeris Biopharma Holdings, Inc. annual D&A?
The current annual D&A of XERS is $12.63M
What is the all-time high annual D&A for Xeris Biopharma Holdings, Inc.?
Xeris Biopharma Holdings, Inc. all-time high annual D&A is $13.16M
What is Xeris Biopharma Holdings, Inc. annual D&A year-on-year change?
Over the past year, XERS annual D&A has changed by -$535.00K (-4.07%)
What is Xeris Biopharma Holdings, Inc. quarterly D&A?
The current quarterly D&A of XERS is $3.16M
What is the all-time high quarterly D&A for Xeris Biopharma Holdings, Inc.?
Xeris Biopharma Holdings, Inc. all-time high quarterly D&A is $3.50M
What is Xeris Biopharma Holdings, Inc. quarterly D&A year-on-year change?
Over the past year, XERS quarterly D&A has changed by +$10.00K (+0.32%)
What is Xeris Biopharma Holdings, Inc. TTM D&A?
The current TTM D&A of XERS is $12.56M
What is the all-time high TTM D&A for Xeris Biopharma Holdings, Inc.?
Xeris Biopharma Holdings, Inc. all-time high TTM D&A is $13.40M
What is Xeris Biopharma Holdings, Inc. TTM D&A year-on-year change?
Over the past year, XERS TTM D&A has changed by -$420.00K (-3.23%)